Rachel Shavit-Bar

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

GPCRs interaction with LGR5: Implications to cancer stemness.

GPCRs interaction with LGR5: Implications to cancer stemness.

Journal: Journal of Cancer

Published: March 20, 2026

PAR2 Serves an Indispensable Role in Controlling PAR4 Oncogenicity: The β-Catenin-p53 Axis.

PAR2 Serves an Indispensable Role in Controlling PAR4 Oncogenicity: The β-Catenin-p53 Axis.

Journal: International journal of molecular sciences

Published: February 12, 2025

New Target(s) for RNF43 Regulation: Implications for Therapeutic Strategies.

New Target(s) for RNF43 Regulation: Implications for Therapeutic Strategies.

Journal: International journal of molecular sciences

Published: June 13, 2024

PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs.

PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs.

Journal: Oncoscience

Published: April 10, 2024

Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design.

Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design.

Journal: Biomedicines

Published: December 18, 2023

PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer.

PAR-Induced Harnessing of EZH2 to β-Catenin: Implications for Colorectal Cancer.

Journal: International journal of molecular sciences

Published: June 12, 2022

PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design.

PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design.

Journal: Molecular cancer therapeutics

Published: November 23, 2021

GPCR Partners as Cancer Driver Genes: Association with PH-Signal Proteins in a Distinctive Signaling Network.

GPCR Partners as Cancer Driver Genes: Association with PH-Signal Proteins in a Distinctive Signaling Network.

Journal: International journal of molecular sciences

Published: July 29, 2021

Transcriptional Landscape of PARs in Epithelial Malignancies.

Transcriptional Landscape of PARs in Epithelial Malignancies.

Journal: International journal of molecular sciences

Published: September 23, 2018

Correction to: Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Correction to: Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Journal: Cancer metastasis reviews

Published: December 21, 2017

Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Cancer driver G-protein coupled receptor (GPCR) induced β-catenin nuclear localization: the transcriptional junction.

Journal: Cancer metastasis reviews

Published: December 10, 2017

Erratum to: Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Erratum to: Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Journal: Cellular and molecular life sciences : CMLS

Published: December 01, 2016

Showing 1-12 of 19

Last Updated: 09/26/2026